Evidence map›Paper›PMID 41259308›Full record

ArticlePloS one2025

A study protocol for the assessment of antibiotic use and bacterial antimicrobial resistance among children under five years of age: Implications for a resource-limited setting.

Onome T Abiri, Troy D Moon, John S Schieffelin, Cynthia A Adinortey, Gustavo Amorim, Isatta Wurie, Donald S Grant, Babatunde Duduyemi, Mohamed Samai

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Onome T AbiriDepartment of Pharmacology and Therapeutics, Faculty of Basic Medical Sciences, College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown, Sierra Leone.ORCID https://orcid.org/0000-0001-6057-7344
Troy D MoonDepartment of Tropical Medicine and Infectious Diseases, Tulane University Celia Scott Weatherhead School of Public Health and Tropical Medicine, New Orleans, Louisiana, United States of America.
John S SchieffelinSections of Paediatric and Adult Infectious Diseases, Tulane University School of Medicine, New Orleans, Louisiana, United States of America.
Cynthia A AdinorteyDepartment of Molecular Biology and Biotechnology, University of Cape Coast, Cape Coast, Ghana.ORCID https://orcid.org/0000-0001-8569-8433
Gustavo AmorimDepartment of Biostatistics, Vanderbilt University Medical Centre, Nashville, Tennessee, United States of America.
Isatta WurieDepartment of Chemical Pathology, Faculty of Laboratory Medicine and Diagnostics, College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown, Sierra Leone.
Donald S GrantDepartment of Community Medicine, Faculty of Clinical Sciences, College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown, Sierra Leone.
Babatunde DuduyemiDepartment of Pathology, Faculty of Basic Medical Sciences, College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown, Sierra Leone.
Mohamed SamaiDepartment of Pharmacology and Therapeutics, Faculty of Basic Medical Sciences, College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown, Sierra Leone.

Funding

West Africa - Tulane University Laboratory Training Fellowship Supplement for Partnership for Research in Emerging Viral Infections Sierra Leone (PREVSL) U2RTW011248U2RTW011248 · FIC · VANDERBILT UNIVERSITY MEDICAL CENTER · PI MOON, D. TROY · 2019 to 2023
$1.3M
Partnership for Research in Emerging Viral Infections-Sierra Leone (PREVSL)D43TW011248 · FIC · TULANE UNIVERSITY OF LOUISIANA · PI DONALD SAMUEL GRANT, Mohamed Samai · 2024 to 2026
$895k
FIC NIH HHS D43 TW011248FIC NIH HHS U2R TW011248
6 · The paper itself

Abstract

backgroundThe irrational use of antibiotics to treat infections in children is a crucial contributing factor to bacterial antimicrobial resistance (AMR), which can have economic and health consequences, such as morbidity and mortality. This study aims to evaluate antibiotic use and AMR in children under five years of age in Sierra Leone.

methodsThis study will be conducted in three hospitals: Ola During Children, Kenema Government, and Magburaka Government Hospitals in Sierra Leone, among healthcare professionals and patients. A mixed-method (qualitative and quantitative) approach will be used to evaluate paediatric health professionals' knowledge, perceptions, and antibiotic prescription practices. Additionally, two cross-sectional sub-studies will assess inpatient and outpatient trends in antibiotic use and consumption in children, and a cross-sectional observational sub-study will investigate bacterial profiles and AMR among children with bloodstream infections. The anatomical therapeutic chemical (ATC) and the World Health Organisation Access, Watch and Reserve (WHO AWaRe) classifications, days of therapy per 1,000 patient days (DOT/1000PDs), and days of therapy per 100 bed days (DOT/100BDs) will be used to determine the use and consumption. The DOT/1,000PDs and DOT/100BDs will be compared with the defined daily dose/1,000 patient days (DDD/1000PDs) and defined daily dose/100 bed days (DDD/100BDs), respectively. A pre-tested interview guide, interviewer-administered questionnaire and data collection tools adapted from previous studies will be employed for data collection. The sample sizes will be determined, and appropriate sampling methods will be used. Data will be analysed thematically using NVivo 15, and descriptive and inferential statistics using the R software. DISCUSSION: The results of this study will inform policymakers and healthcare professionals in developing and/or implementing policies, guidelines, and educational initiatives that will promote antibiotic stewardship among children in Sierra Leone.

Indexed as

Anti-Bacterial AgentsBacterial InfectionsDrug Resistance, BacterialChild, PreschoolCross-Sectional StudiesFemaleHumansInfantInfant, NewbornMaleResource-Limited SettingsSierra LeoneAnti-Bacterial Agents

Identifiers

PMID41259308
PMCPMC12629471

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.